Nervous necrosis virus typically enters host cells via endocytosis, but it can also enter via a process called macropinocytosis.

Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

Though experts are quite sure exactly how retinol may regulate the production of sebum—an oily, waxy substance produced ...

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

LYTENAVATM is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Un ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...

In May 2025, Eli Lilly and Company conducted a study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...